FDA committee backs Pradaxa
September 23, 2010Sales and Marketing Boehringer, Pradaxa, atrial fibrilation
An FDA committee has voted unanimously in favour of approving Pradaxa for stroke prevention in patients with atrial fibrillation. The …
Solid results for AstraZeneca’s oral RA drug
September 23, 2010Research and Development AstraZeneca, Rigel, fostamatinib, rheumatoid arthritis
AstraZeneca’s new oral treatment for rheumatoid arthritis has produced solid results in a phase II trial. Fostamatinib is the first …
Lilly names new VP of communications
September 23, 2010Medical Communications appointment, lilly, medical communications
Jeffrey Winton will next month join Lilly as vice president of communications and take a place on the company’s global …
Gilenya approved as new frontline MS treatment
September 22, 2010Research and Development, Sales and Marketing Cladribine, FDA, Novartis, gilenya
Novartis’ new multiple sclerosis treatment Gilenya has been approved by the FDA, and is set to significantly alter the way …
Lixisenatide shaping up to rival Victoza
September 22, 2010Research and Development Lixisenatide, Sanofi-Aventis, diabetes
Data for Sanofi-Aventis’ injectable lixisenatide suggests it could rival Novo Nordisk’s drug Victoza.Lixisenatide is a once-daily GLP-1 receptor agonist, and …
Outdated HRT website breaches Code
September 22, 2010Medical Communications ABPI, Code of Practice, PMCPA, Pfizer, Wyeth
A website which contained outdated information about the risk of using hormone replacement therapy has been found in breach of …
Tesco to sell cut-price Viagra
September 21, 2010Sales and Marketing Boots, Pfizer, Tesco, supermarket, viagra
Tesco has declared a price war in erectile dysfunction, announcing it will sell Viagra through its in-store pharmacies for less …
Digital Pharma: GSK takes drug information to Europe
September 21, 2010Medical Communications Digital Pharma blog, GlaxoSmithKline, digital patients
European patients can now get information on GlaxoSmithKline’s prescription medicines direct from the company through its expanded health.gsk.com website. The …
J&J’s Weldon will appear at next congressional hearing
September 21, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson chief executive William Weldon will appear in person at the next congressional hearing on the company’s wide-ranging …
Red Door boosts consumer health division
September 21, 2010Medical Communications Red Door, appointment, medical communications
London-based healthcare communications consultancy Red Door has boosted its consumer health division with two senior appointments. Rachel Vrettos has returned …
AAIPharma appoints Patrick Walsh
September 21, 2010Manufacturing and Production AAIPharma, appointment, manufacturing and production
Contract manufacturing and drug development services company AAIPharma has appointed Patrick Walsh as its new chief executive. Walsh has 30 …
Medical, marketing & sales: making cross-functional working work
September 21, 2010Research and Development, Sales and Marketing marketing, sales force effectiveness, sales representatives
A successful market access strategy requires the close collaboration of all functions within a pharmaceutical company. Most notably, the triumvirate …
Pharma manufacturing news in brief
September 21, 2010Manufacturing and Production AAIPharma, Actavis, Japan, KV Pharmaceutical, Purac, Takeda, contract manufacturing
This week’s round-up of pharmaceutical manufacturing news includes updates from Takeda, KV Pharmaceutical, Actavis, AAIPharma and Purac, while Japan’s CMOs …
Public sceptical of pharma research
September 21, 2010Research and Development Animal testing, Animal tests
Businesses including drug companies are seen as broadly untrustworthy or self-serving when it comes to medical research. This is one …
Transition drops new diabetes drug
September 20, 2010Research and Development Transition Therapeutics, diabetes, lilly
Transition Therapeutics is to abandon trials of its new diabetes treatment TT-223 following disappointing trial results. The Canadian biopharma company …
FDA launches safety review of Actos
September 20, 2010Sales and Marketing Actos, Takeda, diabetes
A new safety review of Takeda’s diabetes drug Actos has been launched by the FDA after a long-term study suggested …
Novartis hails longer-lasting COPD drug
September 20, 2010Research and Development, Sales and Marketing COPD, Novartis, Onbrez Breezhaler
A phase III treatment for COPD has demonstrated superior results over GSK’s established Serevent (salmeterol). Data from Novartis’ INSIST study …
GSK workers in Ireland await review
September 20, 2010Manufacturing and Production, Research and Development GlaxoSmithKline, Ireland, job cuts
Workers at a GlaxoSmithKline facility in Ireland are anxiously awaiting the outcome of an official review of the operation amid …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
